Skip to main content
. Author manuscript; available in PMC: 2019 Jul 12.
Published in final edited form as: Contemp Clin Trials. 2018 Apr 5;69:21–27. doi: 10.1016/j.cct.2018.04.001

Table 1.

Schedule of study procedures and assessments

Assessment Frequency
GENERAL
Verbal consent and pre-screening questionnaire Pre-SCR
Informed Consent Form SCR
Demographics SCR
Inclusion/Exclusion criteria SCR
Medical Release Form SCR
Locator Form BSL, then at each study visit
Randomization BSL
SAFETY and MEDICAL ASSESSMENTS
DSM-5 Diagnostic Criteria for OUD SCR
Medical and Psychiatric History SCR
Physical Exam & Vital Signs SCR
Pregnancy and Birth Control Assessment SCR, BSL, W 4, 8, 12, 16, 20, EOT
Concomitant medications SCR, BSL, then at each study visit
Adverse Events and Serious Adverse Events BSL, then at each study visit
Clinical Opiate Withdrawal Scale BSL, W 2, 4, 6
EFFICACY and OTHER ASSESSMENTS
Urine Drug Screen (UDS) SCR, BSL, then every 2 weeks
Assigned OAT - Pharmacy Abstraction BSL, then at each study visit
Assigned OAT - Self-report BSL, then at each study visit
Client Satisfaction Questionnaire-8 W 4, 12, EOT
Treatment Entry Questionnaire BSL
Health Care Climate Questionnaire W4, 12, EOT
Control Preference Scale BSL
CollaboRATE questionnaire BSL, then at each study visit
Health Service Utilization form BSL, W 4, 8, 12, 16, 20, EOT
EuroQol-5D-3L/5L BSL, W 4, 8, 12, 16, 20, EOT
Health Utilities Index - III BSL, W 4, 8, 12, 16, 20, EOT
Brief Pain Inventory - SF BSL, W 6, 12, 18, EOT
Timeline Follow Back BSL, then at each study visit
ASI-Self Report Form SCR and EOT
Beck Depression Inventory - II BSL, W 12, EOT
Beck Anxiety Inventory BSL, W 12, EOT
Kessler Psychological Distress Scale 10 BSL, W 12, EOT
Risk Behaviour Survey BSL, W 12, EOT
Brief Substance Craving Scale BSL, W 2, 4, 8, 12, 16, 20, EOT
TREATMENT
Assigned OAT - Dosing BSL, then W 1 to 24
Medical Management BSL, then as clinically needed

SCR, Screening. BSL, Baseline. EOT, End of Treatment. W, week.